Clinical Investigation of the SelectSecure Pacing Lead

Sponsor
Medtronic Cardiac Rhythm and Heart Failure (Industry)
Overall Status
Completed
CT.gov ID
NCT00266682
Collaborator
(none)
365
31
36
11.8
0.3

Study Details

Study Description

Brief Summary

People who have a slow heart beat, or whose heart does not beat on its own, may be in need of an electronic device called a pacemaker. A pacemaker is implanted surgically just under the skin in the upper chest area. This device helps the heart beat at a regular rhythm by sending electrical signals (pacing) directly to the heart tissue through flexible wires called leads. The purpose of this study is to demonstrate that the SelectSecure (Model 3830) lead is safe and effective for both sensing the heart's natural rhythm and pacing the heart when it does not beat on its own. This lead will be studied in both the right atrium and right ventricle. A previously market approved Medtronic lead model will serve as a comparison to prove the safety and effectiveness of the SelectSecure Model.

Condition or Disease Intervention/Treatment Phase
  • Device: Pacing Lead
N/A

Study Design

Study Type:
Interventional
Allocation:
Non-Randomized
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Clinical Investigation of the SelectSecure Pacing Lead
Study Start Date :
Aug 1, 2002
Study Completion Date :
Aug 1, 2005

Outcome Measures

Primary Outcome Measures

  1. 3-month safety (complications and all lead-related adverse events) and efficacy ( pacing and sensing) objectives []

Secondary Outcome Measures

  1. Lead and catheter handling characteristics, and lead impedance []

Eligibility Criteria

Criteria

Ages Eligible for Study:
0 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Subjects who are in need of a pacemaker that paces in both the right atrium and ventricle.

Exclusion Criteria:

Subjects who are in need of an implantable cardioverter defibrillator (ICD).

Subjects who have a mechanical or diseased tricuspid valve (a structure in the heart, located between the right atrium and right ventricle, which allows blood to flow from the atrium to the ventricle).

Steroid contraindication

Contacts and Locations

Locations

Site City State Country Postal Code
1 Anchorage Alaska United States
2 Peoria Arizona United States
3 Long Beach California United States
4 Santa Rosa California United States
5 Fort Lauderdale Florida United States
6 Evanston Illinois United States
7 Indianapolis Indiana United States
8 Des Moines Iowa United States
9 Iowa City Iowa United States
10 Kansas City Kansas United States
11 Boston Massachusetts United States
12 Detroit Michigan United States
13 Robbinsdale Minnesota United States
14 St. Paul Minnesota United States
15 Kansas City Missouri United States
16 Springfield Missouri United States
17 Livingston New Jersey United States
18 Winston-Salem North Carolina United States
19 Cincinnati Ohio United States
20 Lancaster Pennsylvania United States
21 Sayre Pennsylvania United States
22 Germantown Tennessee United States
23 Nashville Tennessee United States
24 Austin Texas United States
25 Temple Texas United States
26 Richmond Virginia United States
27 Melbourne Australia
28 Kingston Canada
29 London Canada
30 Ottawa Canada
31 Sainte-Foy Canada

Sponsors and Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00266682
Other Study ID Numbers:
  • 600
First Posted:
Dec 19, 2005
Last Update Posted:
Oct 13, 2006
Last Verified:
Oct 1, 2006
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 13, 2006